Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Anaïs Paris"'
Autor:
Anaïs Paris, Nina Tardif, Francesca M Baietti, Cyrille Berra, Héloïse M Leclair, Eleonora Leucci, Marie‐Dominique Galibert, Sébastien Corre
Publikováno v:
EMBO Molecular Medicine, Vol 14, Iss 12, Pp n/a-n/a (2022)
Abstract The nongenetic mechanisms required to control tumor phenotypic plasticity and shape drug‐resistance remain unclear. We show here that the Aryl hydrocarbon Receptor (AhR) transcription factor directly regulates the gene expression program a
Externí odkaz:
https://doaj.org/article/18e95c983816457ca7f883a9359acf88
Autor:
Arthur Gautron, Laura Bachelot, Marc Aubry, Delphine Leclerc, Anaïs M Quéméner, Sébastien Corre, Florian Rambow, Anaïs Paris, Nina Tardif, Héloïse M Leclair, Oskar Marin‐Bejar, Cédric Coulouarn, Jean‐Christophe Marine, Marie‐Dominique Galibert, David Gilot
Publikováno v:
EMBO Molecular Medicine, Vol 13, Iss 5, Pp n/a-n/a (2021)
Abstract Most genetic alterations that drive melanoma development and resistance to targeted therapy have been uncovered. In contrast, and despite their increasingly recognized contribution, little is known about the non‐genetic mechanisms that dri
Externí odkaz:
https://doaj.org/article/aca2254b33d042efb8994b39d40584e3
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 2, p 752 (2021)
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that has been shown to be an essential regulator of a broad spectrum of biological activities required for maintaining the body’s vital functions. AhR also plays a criti
Externí odkaz:
https://doaj.org/article/5005fc46c91948738913f7f7035cb603
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 14, p 5025 (2020)
BRAF and MEK inhibitors (BRAFi and MEKi) are the standard of care for the treatment of metastatic melanoma in patients with BRAFV600E mutations, greatly improving progression-free survival. However, the acquisition of resistance to BRAFi and MEKi rem
Externí odkaz:
https://doaj.org/article/bcf13d4d966348959b24a6f14a9a4e93
Autor:
Anaïs Paris, Nina Tardif, Francesca M Baietti, Cyrille Berra, Héloïse M Leclair, Eleonora Leucci, Marie‐Dominique Galibert, Sébastien Corre
Publikováno v:
EMBO Molecular Medicine
EMBO Molecular Medicine, 2022, 14 (12), pp.e15677. ⟨10.15252/emmm.202215677⟩
EMBO Molecular Medicine, 2022, 14 (12), pp.e15677. ⟨10.15252/emmm.202215677⟩
The nongenetic mechanisms required to control tumor phenotypic plasticity and shape drug-resistance remain unclear. We show here that the Aryl hydrocarbon Receptor (AhR) transcription factor directly regulates the gene expression program associated w
Autor:
Anais M. Quemener, Florian Rambow, Arthur Gautron, Delphine Leclerc, Héloïse M Leclair, Marc Aubry, Cédric Coulouarn, Anaïs Paris, Marie-Dominique Galibert, Laura Bachelot, Jean-Christophe Marine, Nina Tardif, Sébastien Corre, Oskar Marín-Béjar, David Gilot
Publikováno v:
EMBO Molecular Medicine
EMBO Molecular Medicine, 2021, 13 (5), pp.e13466. ⟨10.15252/emmm.202013466⟩
EMBO Molecular Medicine, Wiley Open Access, 2021, 13 (5), pp.e13466. ⟨10.15252/emmm.202013466⟩
EMBO Molecular Medicine, Vol 13, Iss 5, Pp n/a-n/a (2021)
EMBO Molecular Medicine, 2021, 13 (5), pp.e13466. ⟨10.15252/emmm.202013466⟩
EMBO Molecular Medicine, Wiley Open Access, 2021, 13 (5), pp.e13466. ⟨10.15252/emmm.202013466⟩
EMBO Molecular Medicine, Vol 13, Iss 5, Pp n/a-n/a (2021)
Most genetic alterations that drive melanoma development and resistance to targeted therapy have been uncovered. In contrast, and despite their increasingly recognized contribution, little is known about the non‐genetic mechanisms that drive these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::848a2d05a3c0790e3945e46a9816f4d9
https://hal.science/hal-03194524
https://hal.science/hal-03194524
Autor:
Anais M. Quemener, Nina Tardif, Sébastien Corre, Marc Aubry, David Gilot, Arthur Gautron, Anaïs Paris, Laura Bachelot, Marie-Dominique Galibert, Jean-Christophe Marine, Cédric Coulouarn, Florian Rambow, Héloïse M Leclair
Most genetic alterations that drive melanoma development and resistance to targeted therapy have been uncovered. In contrast, and despite their increasingly recognized contribution, little is known about the non-genetic mechanisms that drive these pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6be7bfb99c6829b0d59e8858b61ba0af
https://doi.org/10.1101/2020.07.08.193102
https://doi.org/10.1101/2020.07.08.193102
Autor:
Thomas Mouillot, Anaïs Parise, Camille Greco, Sophie Barthet, Marie-Claude Brindisi, Luc Penicaud, Corinne Leloup, Laurent Brondel, Agnès Jacquin-Piques
Publikováno v:
Nutrients, Vol 12, Iss 2, p 322 (2020)
Aspartame and Stevia are widely substituted for sugar. Little is known about cerebral activation in response to low-caloric sweeteners in comparison with high-caloric sugar, whereas these molecules lead to different metabolic effects. We aimed to com
Externí odkaz:
https://doaj.org/article/69d1de9010e84b16a077ee3ad5ce66fa